Literature DB >> 1676893

Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity.

S A Lipton1, N J Sucher, P K Kaiser, E B Dreyer.   

Abstract

Exposure of rat retinal cultures to HIV-1 coat protein gp120 for several minutes increases [Ca2+]i in approximately half of the ganglion cells; this effect is associated with delayed-onset neuronal injury, similar to that previously reported in NMDA receptor-mediated neurotoxicity. Here we show that NMDA antagonists can prevent both the rise in [Ca2+]i and subsequent neuronal damage engendered by 20 pM gp120. However, whole-cell patch-clamp recordings demonstrate that gp120 does not directly evoke an NMDA-like response or enhance glutamate/NMDA-activated currents. Moreover, complete protection from gp120-induced [Ca2+]i increases and neurotoxicity is afforded by incubation with glutamate-pyruvate transaminase, which breaks down endogenous glutamate as verified by HPLC. Since, under standard conditions in these cultures, neither glutamate nor a low picomolar concentration of gp120 is deleterious on its own, our results suggest that their neurotoxicity is synergistic.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676893     DOI: 10.1016/0896-6273(91)90079-f

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  97 in total

1.  Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

Authors:  K L Jordan-Sciutto; G Wang; M Murphy-Corb; C A Wiley
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  CXCL12 signaling in the development of the nervous system.

Authors:  Divakar S Mithal; Ghazal Banisadr; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-21       Impact factor: 4.147

Review 3.  Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Blaise Mathias-Costa; Vijeta Singh; Pankaj Seth; John Wang; Tsung-Ping Su
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 4.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

5.  Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression.

Authors:  S Rasty; P Thatikunta; J Gordon; K Khalili; S Amini; J C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosum.

Authors:  Jingdong Zhang; Jianuo Liu; Bryan Katafiasz; Howard Fox; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-02       Impact factor: 4.147

7.  Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex.

Authors:  D J Benos; B H Hahn; J K Bubien; S K Ghosh; N A Mashburn; M A Chaikin; G M Shaw; E N Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

Review 8.  HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis.

Authors:  Marcus Kaul
Journal:  Front Biosci       Date:  2008-01-01

9.  Developmental expression of N-methyl-D-aspartate (NMDA)-induced neurotoxicity, NMDA receptor function, and the NMDAR1 and glutamate-binding protein subunits in cerebellar granule cells in primary cultures.

Authors:  Y Xia; R E Ragan; E E Seah; M L Michaelis; E K Michaelis
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

10.  Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization.

Authors:  Alessia Bachis; Eugene O Major; Italo Mocchetti
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.